Division News

Duke Human Vaccine Team awarded $5 million to study fungal fever

The Duke Human Vaccine Institute’s Vaccine and Treatment Evaluation Unit has been awarded a $5 million contract from the National Institute of Allergy and Infectious Disease to support further research on Valley Fever Pneumonia.

Valley Fever Pneumonia is caused by the fungal pathogens Coccidioides posadasii and Coccidioides immitis, which primarily live in soil. Valley Fever is endemic in certain parts of the southwestern United States, including Arizona and California.

Prudhomme-O'Meara receives supplemental Duke CTSA award

Wendy Prudhomme-O'Meara, PhD, assistant professor of medicine (Infectious Diseases) and global health, has received a supplemental award through Duke Translational Research. The award will provide supplemental funding for the project "Novel mHealth platform to ensure quality of community-based malaria diagnosis."

The research evaluates an innovative public-private partnership in Kenya using trained community health workers to target malarial medicines to those with confirmed malaria infection.

Klotman awarded 5-year program project grant from NIAID

The National Institutes of Health has awarded a research program project grant to Mary Klotman, MD, professor of medicine (Infectious Diseases). The award will last five years, and will total more than $9 million.

The program project, "Integrase Defective Lentiviral Vector (IDLV)-ENV Immunogen Strategy for an HIV Vaccine," is supported by the National Institute Of Allergy and Infectious Diseases under award number P01AI110485.

Philanthropies announce new program to support early-career scientists

Three of the nation’s largest philanthropies – the Howard Hughes Medical Institute, the Bill & Melinda Gates Foundation, and the Simons Foundation – have announced a new partnership to provide much needed research support to outstanding early-career scientists in the United States.

Through the new Faculty Scholars Program, the philanthropies will invest a total of $148 million in research support over the program’s first five years.